MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 138 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $99,000 | -57.1% | 79,599 | +5.9% | 0.00% | -100.0% |
| Q1 2017 | $231,000 | -19.2% | 75,158 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $286,000 | -99.9% | 70,183 | -0.3% | 0.00% | -50.0% |
| Q3 2016 | $446,811,000 | +18.0% | 70,364 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $378,685,000 | -29.7% | 70,257 | +9.0% | 0.00% | 0.0% |
| Q1 2016 | $539,000,000 | +5.9% | 64,441 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $509,000,000 | +92614.0% | 64,441 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $549,000 | -99.9% | 64,553 | +0.1% | 0.00% | -33.3% |
| Q2 2015 | $797,246,000 | +8.7% | 64,476 | +4.4% | 0.00% | 0.0% |
| Q1 2015 | $733,388,000 | +5.1% | 61,733 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $697,583,000 | +21.5% | 61,733 | -5.6% | 0.00% | 0.0% |
| Q3 2014 | $574,001,000 | +22.6% | 65,376 | +1.8% | 0.00% | +50.0% |
| Q2 2014 | $468,186,000 | +39.3% | 64,223 | -3.7% | 0.00% | 0.0% |
| Q1 2014 | $336,188,000 | -3.3% | 66,704 | +2.4% | 0.00% | 0.0% |
| Q4 2013 | $347,764,000 | +47.8% | 65,126 | +5.2% | 0.00% | +100.0% |
| Q3 2013 | $235,248,000 | +233.7% | 61,910 | +491.1% | 0.00% | – |
| Q2 2013 | $70,490,000 | – | 10,474 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|